<DOC>
	<DOCNO>NCT00976196</DOCNO>
	<brief_summary>The PHP study aim delineate gene product involve high on-treatment platelet reactivity aspirin-treated cardiovascular patient .</brief_summary>
	<brief_title>Platelet Hyperreactivity Project</brief_title>
	<detailed_description>The PHP study aim delineate gene product involve high on-treatment platelet reactivity aspirin-treated cardiovascular patient use system biology approach include proteomics analysis select platelet sub-fractions patient display extreme phenotype . Main objective : - characterize proteome profile platelet hyperreactivity aspirin-treated cardiovascular patient Secondary objective : - characterize platelet hyperreactivity phenotype cardiovascular patient treat aspirin - determine genetic polymorphism associate platelet hyperreactivity</detailed_description>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Documented symptomatic ischemic atherothrombotic disease treat aspirin . Known platelet disorder Chronic treatment antiplatelet drug aspirin Chronic anticoagulant treatment Chronic non steroidal antiinflammatory drug treatment Active cancer Treatment serotonin reuptake inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Aspirin</keyword>
	<keyword>Blood platelet</keyword>
	<keyword>proteomics</keyword>
	<keyword>Platelet reactivity</keyword>
</DOC>